Notes from the article:
Mistletoe therapy worked synergistically with Chemotherapy and Radiation
The authors concluded that Mistletoe Therapy should be a treatment option
Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe
Notes from the study:
Those receiving the Mistletoe Therapy took twice as long to show sign of disease recurrence
Those receiving Mistletoe Therapy lived twice as long as well
Study on Low Dose Temozolomide Plus Metformin or Placebo in Patient With Recurrent or Refractory Glioblastoma (METT)
In 12 locations in South Korea for those experiencing Recurrence or Progression
Continue readingA Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Located in New York, NY, eligibility is Open
Continue readingMetformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by Adjuvant TMZ in Patients With GBM
Based out of McGill University in Canada for Patients Newly Diagnosed
Continue readingMetformin influences progression in diabetic glioblastoma patients
Notes from the study:
Metformin usage by diabetic patients was correlated with a higher percentage of desired outcomes
Metformin as Potential Therapy for High-Grade Glioma
Notes from the article:
Low toxic and usually well-tolerated, Metformin appears to increase the effectiveness of both chemotherapy and radiation
Melatonin’s Antineoplastic Potential Against Glioblastoma
Notes from the article:
The authors of this study call the lab experiments involving Melatonin “remarkable”
The authors also find it to be a promising agent in the fight against cancer
Role and Therapeutic Potential of Melatonin in the Central Nervous System and Cancers
Notes from the article:
Chemoprotective and an effective cancer-fighting agent, the authors call for more cancer studies involving Melatonin
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone
Notes from the study:
Melatonin supplementation led to both longer survival time and disease-free progression